Aegon Ltd. · AEG · FY2025 Q2 · Calendar Q3 2025
Aegon sustains guidance as U.S. growth and capital returns advance
The supplied analysis supports a constructive but conditional view: U.S.-led operating momentum and capital returns strengthen the case for resilient earnings, while the relocation, accounting transition, market sensitivity, and claims risks keep the outlook dependent on execution.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about AEG FY2025 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior analysis, the current analysis indicates stronger operating performance, expanded capital returns, a broader variable-annuity hedge, and a newly active review of U.S. domicile, headquarters, and U.S. GAAP reporting. Guidance sentiment remained maintained.
Guidance delta
Maintained; the supplied analysis says 2025 operating-result and operating-capital-generation objectives were kept essentially unchanged.
Key takeaways
- The supplied analysis describes stronger operating performance, led primarily by the U.S. business.
- Capital returns were increased through a higher interim dividend and additional buyback capacity.
- Management is reviewing a U.S. relocation and U.S. GAAP transition while extending hedging for variable-annuity exposure.
- The main counterweights are implementation complexity, market sensitivity, claims experience, and new-business strain.
Management priorities
- Advance U.S. growth through life, retirement, RILA, and digital-product initiatives.
- Complete the U.S. GAAP implementation work and decide on the proposed U.S. legal and head-office structure.
- Continue capital returns while managing capital-generation volatility and variable-annuity exposure.
Follow AEG with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 2, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Equal Weight | Overweight | Downgrade | May 15, 2026 |
| UBS | Neutral | Buy | Downgrade | Dec 3, 2025 |
| Exane BNP Paribas | Outperform | Neutral | Upgrade | May 7, 2025 |
| Credit Suisse | Outperform | Neutral | Upgrade | Nov 24, 2021 |
| Societe Generale | Hold | Sell | Upgrade | Apr 20, 2021 |
| Citigroup | Sell | Neutral | Downgrade | Jan 17, 2019 |
| Bank of America | Underperform | Neutral | Downgrade | Jun 15, 2018 |
| B of A Securities | Underperform | Neutral | Downgrade | Jun 14, 2018 |
| ING | Hold | Buy | Downgrade | Dec 1, 2016 |
| Ingalls & Snyder, LLC | Hold | Buy | Downgrade | Nov 30, 2016 |
| Barclays | Underweight | Equal Weight | Downgrade | Jun 29, 2016 |
| JP Morgan | Neutral | Overweight | Downgrade | Jun 28, 2016 |
| RBC Capital | Sector Perform | Outperform | Downgrade | Dec 10, 2015 |
| Goldman Sachs | Buy | Neutral | Upgrade | Sep 24, 2015 |
| Jefferies | Buy | Hold | Upgrade | Jul 20, 2015 |
| ABN Amro | Hold | Buy | Downgrade | Mar 26, 2015 |
| Canaccord Genuity | Buy | Buy | Maintain | Nov 19, 2013 |
| Mediobanca Securities | Neutral | Outperform | Downgrade | Jan 8, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $8.5. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| CFRA | Jeff Lye | $7.5 | $6.82 | -11.8% | May 16, 2024 |
Track every rating change on AEG the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationAegon Ltd. functions as a leading financial services provider, offering a comprehensive suite of insurance, retirement planning, and asset management solutions across its operational regions in the Americas, the Netherlands, and the United Kingdom. The company's diverse product range includes life, accident, and health insurance, alongside property and casualty coverage. It also facilitates wealth growth and retirement security through savings vehicles, pensions, annuities, mutual funds, individual retirement accounts, voluntary employee benefits, and stable value programs. Beyond these, Aegon deals in various financial instruments such as debt and mortgage-backed securities, derivatives, reinsurance assets, and short-term investments, while also delivering services like credit risk management, disability assistance, and innovative digital banking platforms. Established in 1983 as Aegon N.V., the firm's main offices are located in The Hague, Netherlands.
Historical context
All AEG earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| FDS FactSet Research Systems Inc. | FY2026 Q4 · Calendar Q3 2026 | +3.9% | +3.8% | FactSet reports record FY26 results as AI and MCP adoption accelerate |
| PUK Prudential plc | FY2026 Q2 · Calendar Q3 2026 | -40.9% | -0.5% | Prudential sustains growth and capital returns focus in H1 2026 |
| CM Canadian Imperial Bank of Commerce | FY2026 Q3 · Calendar Q3 2026 | +8.9% | -2.8% | CIBC Q3: Broad growth, resilient credit and expanded AI rollout |
| TD The Toronto-Dominion Bank | FY2026 Q3 · Calendar Q3 2026 | +13.8% | +1.4% | TD emphasizes growth investments alongside disciplined capital management |
| RY Royal Bank of Canada | FY2026 Q3 · Calendar Q3 2026 | +6.2% | -1.3% | RBC reports record Q3 earnings while investing for growth |
| AFRM Affirm Holdings, Inc. | FY2026 Q4 · Calendar Q3 2026 | +1230.3% | +0.3% | Affirm's most profitable quarter shifts focus to product execution |
Latest beats and misses
Who reports nextBeat on EPS
- ACNFY2026 Q4 · October 1, 2026+3.5% EPS+15.8% move
- MKCFY2026 Q3 · October 1, 2026+13.9% EPS-4.9% move
- NKEFY2027 Q1 · October 1, 2026+10.0% EPS-0.7% move
- CAGFY2027 Q1 · September 30, 2026+44.4% EPS-4.9% move
- FDSFY2026 Q4 · September 30, 2026+3.9% EPS+3.8% move
- JBLFY2026 Q4 · September 30, 2026+8.1% EPS-10.0% move
Get the AEG recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:36:15.940040+00:00
- Polygon adjusted daily market bars · 2026-10-02T15:26:11.055834+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-02T15:26:11.052796+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-02. For educational purposes only; not investment advice.